Vitamin D3 (as Cholecalciferol)
Vitamin D3 (cholecalciferol) is a fat-soluble secosteroid hormone precursor synthesised in the skin through UVB sunlight exposure and found in oily fish, egg yolks, and fortified foods, that regulates calcium absorption, immune modulation, and hormonal signalling — making it one of the most widely deficient nutrients for women over 35 in New Zealand. In element3 Rise (AM Formula), vitamin D3 is provided at 10mcg as cholecalciferol to support normal immune function, hormone levels, mood and bone health.
[ 01 ] Key Facts
| Dose in element3 | element3 Rise: 10mcg |
|---|---|
| Form | Cholecalciferol (D3) — the bioactive form identical to what skin produces from sunlight; superior to ergocalciferol (D2) |
| Signs you may need more | Fatigue, low mood (especially seasonal), frequent illness, bone or muscle pain, slow wound healing |
| Safe range | Upper intake level is typically 4,000 IU/day (100mcg). Blood levels of 25(OH)D above 50 nmol/L are considered sufficient; 75–125 nmol/L is optimal. |
Food sources
- Oily fish (salmon, mackerel)
- Egg yolks
- Fortified dairy
- Cod liver oil
[ 02 ] Rationale
Why this ingredient is in element3
[ 03 ] Formulator's Notes
From the formulator
Vitamin D works alongside K2 and calcium for bone health, and it's one of the nutrients supporting normal immune function.
Lucy Yang · Principal Food Technologist, element³
[ 04 ] At 35+
Relevant at 35+
[ 05 ] Your Questions
Your Questions
What is vitamin D3?
What are the benefits of taking vitamin D3?
What are the benefits of vitamin D3 in the element³ protocol?
What is the recommended daily intake of vitamin D3?
What food provides vitamin D3?
Are there any vitamin D3 side effects?
What are vitamin D3 deficiency symptoms?
What form of vitamin D is in the element³ blend?
How much vitamin D3 should I take daily?
Vitamin K2 and D3 — why take them together?
What is the difference between vitamin D2 and D3?
Vitamin D3 in NZ— are New Zealanders deficient?
[ 06 ] The Research
The Research
| Study | Key finding | Read |
|---|---|---|
| Calcium plus Vitamin D Supplementation and the Risk of FracturesJackson RD, LaCroix AZ, Gass M, et al; Women's Health Initiative Investigators. Calcium plus Vitamin D Supplementation and the Risk of Fractures. New England Journal of Medicine. 2006;354(7):669–683. doi:10.1056/NEJMoa055218. PMID: 16481635. | One of the largest clinical trials ever conducted in postmenopausal women provides direct evidence at this vitamin D dose. 36,282 postmenopausal women were randomly assigned to 1,000 mg of calcium plus 400 IU of vitamin D3 daily or placebo, over an average of 7 years. Hip bone density was 1.06 percent higher in the calcium plus vitamin D group than in the placebo group (P<0.01), a small but statistically significant improvement. Because the trial was conducted entirely in postmenopausal women, the finding is directly applicable to women in mid-life and beyond, with no extrapolation from male data. The vitamin D was given alongside calcium, reflecting vitamin D3's central role: enabling the body to absorb and use dietary calcium. |
Read → |
| Vitamin D3 + K2 (MK-7) combination — Kanellakis et al., 2012Kanellakis S, Moschonis G, Tenta R, Schaafsma A, van den Heuvel EGHM, Papaioannou N, Lyritis G, Manios Y. Changes in Parameters of Bone Metabolism in Postmenopausal Women Following a 12-Month Intervention Period Using Dairy Products Enriched with Calcium, Vitamin D, and Phylloquinone (Vitamin K1) or Menaquinone-7 (Vitamin K2): The Postmenopausal Health Study II. Calcified Tissue International. 2012;90(4):251–262. doi:10.1007/s00223-012-9571-z. PMID: 22392526. | This 12-month randomized trial tested vitamin D3 at 10 µg (400 IU) together with vitamin K2 in the long-chain MK-7 form, in postmenopausal women. Participants received fortified dairy providing 800 mg of calcium and 400 IU of vitamin D3 daily, with two groups additionally receiving 100 µg of either vitamin K1 or menaquinone-7 (K2). Serum 25(OH)D, the marker of vitamin D status — rose significantly across all supplemented groups versus control, and serum IGF-I, a growth factor involved in bone maintenance, rose significantly in the MK-7 group. The two vitamin K groups showed more favourable changes in bone metabolism and bone-mass indices, reflected in suppressed bone-remodelling markers and more positive changes in lumbar-spine bone mineral density. Conducted in postmenopausal women, the results speak directly to bone health in this age group. |
Read → |
| Investigating the Effects and Mechanisms of Combined Vitamin D and K Supplementation in Postmenopausal Women: An Up-to-Date Comprehensive Review of Clinical StudiesReference: Rusu ME, Bigman G, Ryan AS, Popa DS. Investigating the Effects and Mechanisms of Combined Vitamin D and K Supplementation in Postmenopausal Women: An Up-to-Date Comprehensive Review of Clinical Studies. Nutrients. 2024;16(14):2356. doi:10.3390/nu16142356. PMID: 39064799. | This 2024 review is the first to comprehensively synthesise the randomized-trial evidence for vitamin D and vitamin K taken together in postmenopausal women. Across 31 relevant randomized controlled trials, the authors concluded that combined intake of vitamins D and K may positively affect both cardiovascular and bone health in postmenopausal women, and recommended vitamin D and K supplementation to support healthy aging where diet alone falls short. It provides the broader evidence base for the rationale of pairing the two vitamins in women navigating menopause and beyond |
Read → |
[ 07 ] In the Protocol
Where Vitamin D3 (as Cholecalciferol) sits in the element3 Protocol
Good to know
This page is for general education only. It is not medical advice and is not a substitute for advice from your doctor, pharmacist or other health professional. Dietary supplements should not replace a balanced diet. Always read the label and use only as directed. If symptoms persist, or you are pregnant, breastfeeding or taking medication, talk to your health professional before use.
